Loading…
Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation
Systems for the staging of individuals with human immunodeficiency virus type 1 (HIV-1) infection were developed 15 years ago. Subsequently, assays for quantitating HIV-1 RNA and immunophenotyping of lymphocyte subsets have been developed and validated. The utility of these assays for improved stagi...
Saved in:
Published in: | Military medicine 2001-07, Vol.166 (7), p.571-576 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3081-21966eb40e9a781968d4c9ca9ae242871cf60c647bd7d756ee0df394f1c8b1503 |
---|---|
cites | |
container_end_page | 576 |
container_issue | 7 |
container_start_page | 571 |
container_title | Military medicine |
container_volume | 166 |
creator | BROWN, Arthur E DOLAN, Matthew J MALONE, John D GARNER, Robin BIRX, Deborah L MICHAEL, Nelson L ZHOU, Susan PERFETTO, Stephen P HAWKES, Clifton ROBB, Merlin LANE, James MAYERS, Douglas MCNEIL, John G |
description | Systems for the staging of individuals with human immunodeficiency virus type 1 (HIV-1) infection were developed 15 years ago. Subsequently, assays for quantitating HIV-1 RNA and immunophenotyping of lymphocyte subsets have been developed and validated. The utility of these assays for improved staging in early disease was evaluated in 256 HIV-infected adults (52% minority) with CD4 counts > or = 400 cells/microL followed in U.S. military medical centers before the highly active anti-retroviral therapy era. HIV viral load (RNA) was quantitated; the frequencies of select CD4+ immunophenotypes were determined in 112 subjects. The results were analyzed in relation to three outcome measures: death, first acquired immunodeficiency syndrome-defining opportunistic infection, and CD4 count < or = 200 cells/microL. Serum RNA level and CD4 count were each found to be predictive of all three outcomes. In addition, increases in the T-cell subsets CD28-CD4+ and CD29+CD26-CD4+ were found to be independently predictive of more rapid progression. The classification of early-stage HIV patients is improved by the quantitation of both viral RNA and T-lymphocyte subsets. |
doi_str_mv | 10.1093/milmed/166.7.571 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71032983</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71032983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3081-21966eb40e9a781968d4c9ca9ae242871cf60c647bd7d756ee0df394f1c8b1503</originalsourceid><addsrcrecordid>eNpdkU9rFDEchoModq3ePUkQET3MNr_JTDLprSytLRQFqeItZDKZbspMss0fZT6LX9Ysu4h4CuF93peQB6HXQNZABD2b7TSb4QwYW_N1y-EJWoGgpGJAfzxFK0JqVjWEtyfoRYwPhEAjOniOTgAaJkq4Qr83k3VWqwnvgr93PtqI_Yh3KlnjUsS_bNpio8K0VDGpe4O3eVYO23nOzg9mtLpwesE_bcgRf7i--f4RDzYaFQ0-xxvvUrB9Tta7_WyJK8BfP19g5QZ8h6dl3m29XpLBMffRJPyYlUs2qX3jJXo2qimaV8fzFH27urzbXFe3Xz7dbC5uK01JB1UNgjHTN8QIxbty6YZGC62EMnVTdxz0yIhmDe8HPvCWGUOGkYpmBN310BJ6it4fdssXPGYTk5xt1GaalDM-R8mB0Fp0tIBv_wMffA6uvE3WwAkjINoCkQOkg48xmFHugp1VWCQQubcmD9ZksSa5LNZK5c1xN_f75G_hqKkA746AisXVGJTTNv4zzBgtzv8AM3iiKQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217060195</pqid></control><display><type>article</type><title>Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation</title><source>Oxford Journals Online</source><creator>BROWN, Arthur E ; DOLAN, Matthew J ; MALONE, John D ; GARNER, Robin ; BIRX, Deborah L ; MICHAEL, Nelson L ; ZHOU, Susan ; PERFETTO, Stephen P ; HAWKES, Clifton ; ROBB, Merlin ; LANE, James ; MAYERS, Douglas ; MCNEIL, John G</creator><creatorcontrib>BROWN, Arthur E ; DOLAN, Matthew J ; MALONE, John D ; GARNER, Robin ; BIRX, Deborah L ; MICHAEL, Nelson L ; ZHOU, Susan ; PERFETTO, Stephen P ; HAWKES, Clifton ; ROBB, Merlin ; LANE, James ; MAYERS, Douglas ; MCNEIL, John G ; RGP160 Phase IIA Vaccine Investigators ; RGP160 Phase IIA Vaccine Investigators</creatorcontrib><description>Systems for the staging of individuals with human immunodeficiency virus type 1 (HIV-1) infection were developed 15 years ago. Subsequently, assays for quantitating HIV-1 RNA and immunophenotyping of lymphocyte subsets have been developed and validated. The utility of these assays for improved staging in early disease was evaluated in 256 HIV-infected adults (52% minority) with CD4 counts > or = 400 cells/microL followed in U.S. military medical centers before the highly active anti-retroviral therapy era. HIV viral load (RNA) was quantitated; the frequencies of select CD4+ immunophenotypes were determined in 112 subjects. The results were analyzed in relation to three outcome measures: death, first acquired immunodeficiency syndrome-defining opportunistic infection, and CD4 count < or = 200 cells/microL. Serum RNA level and CD4 count were each found to be predictive of all three outcomes. In addition, increases in the T-cell subsets CD28-CD4+ and CD29+CD26-CD4+ were found to be independently predictive of more rapid progression. The classification of early-stage HIV patients is improved by the quantitation of both viral RNA and T-lymphocyte subsets.</description><identifier>ISSN: 0026-4075</identifier><identifier>EISSN: 1930-613X</identifier><identifier>DOI: 10.1093/milmed/166.7.571</identifier><identifier>PMID: 11469026</identifier><identifier>CODEN: MMEDA9</identifier><language>eng</language><publisher>Bethesda, MD: Association of Military Surgeons</publisher><subject>Acquired immune deficiency syndrome ; Adult ; AIDS ; Biological and medical sciences ; Chi-Square Distribution ; Disease Progression ; Female ; HIV ; HIV Infections - immunology ; HIV-1 ; Human immunodeficiency virus ; Human viral diseases ; Humans ; Immune system ; Infections ; Infectious diseases ; Lymphocyte Count ; Lymphocytes ; Male ; Medical prognosis ; Medical sciences ; Outcome Assessment (Health Care) ; Prognosis ; Proportional Hazards Models ; RNA, Viral - blood ; Statistics, Nonparametric ; Survival Analysis ; T-Lymphocyte Subsets ; Vaccines ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>Military medicine, 2001-07, Vol.166 (7), p.571-576</ispartof><rights>2001 INIST-CNRS</rights><rights>Copyright Association of Military Surgeons of the United States Jul 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3081-21966eb40e9a781968d4c9ca9ae242871cf60c647bd7d756ee0df394f1c8b1503</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1066361$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11469026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BROWN, Arthur E</creatorcontrib><creatorcontrib>DOLAN, Matthew J</creatorcontrib><creatorcontrib>MALONE, John D</creatorcontrib><creatorcontrib>GARNER, Robin</creatorcontrib><creatorcontrib>BIRX, Deborah L</creatorcontrib><creatorcontrib>MICHAEL, Nelson L</creatorcontrib><creatorcontrib>ZHOU, Susan</creatorcontrib><creatorcontrib>PERFETTO, Stephen P</creatorcontrib><creatorcontrib>HAWKES, Clifton</creatorcontrib><creatorcontrib>ROBB, Merlin</creatorcontrib><creatorcontrib>LANE, James</creatorcontrib><creatorcontrib>MAYERS, Douglas</creatorcontrib><creatorcontrib>MCNEIL, John G</creatorcontrib><creatorcontrib>RGP160 Phase IIA Vaccine Investigators</creatorcontrib><creatorcontrib>RGP160 Phase IIA Vaccine Investigators</creatorcontrib><title>Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation</title><title>Military medicine</title><addtitle>Mil Med</addtitle><description>Systems for the staging of individuals with human immunodeficiency virus type 1 (HIV-1) infection were developed 15 years ago. Subsequently, assays for quantitating HIV-1 RNA and immunophenotyping of lymphocyte subsets have been developed and validated. The utility of these assays for improved staging in early disease was evaluated in 256 HIV-infected adults (52% minority) with CD4 counts > or = 400 cells/microL followed in U.S. military medical centers before the highly active anti-retroviral therapy era. HIV viral load (RNA) was quantitated; the frequencies of select CD4+ immunophenotypes were determined in 112 subjects. The results were analyzed in relation to three outcome measures: death, first acquired immunodeficiency syndrome-defining opportunistic infection, and CD4 count < or = 200 cells/microL. Serum RNA level and CD4 count were each found to be predictive of all three outcomes. In addition, increases in the T-cell subsets CD28-CD4+ and CD29+CD26-CD4+ were found to be independently predictive of more rapid progression. The classification of early-stage HIV patients is improved by the quantitation of both viral RNA and T-lymphocyte subsets.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adult</subject><subject>AIDS</subject><subject>Biological and medical sciences</subject><subject>Chi-Square Distribution</subject><subject>Disease Progression</subject><subject>Female</subject><subject>HIV</subject><subject>HIV Infections - immunology</subject><subject>HIV-1</subject><subject>Human immunodeficiency virus</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immune system</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Lymphocyte Count</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical sciences</subject><subject>Outcome Assessment (Health Care)</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>RNA, Viral - blood</subject><subject>Statistics, Nonparametric</subject><subject>Survival Analysis</subject><subject>T-Lymphocyte Subsets</subject><subject>Vaccines</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>0026-4075</issn><issn>1930-613X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpdkU9rFDEchoModq3ePUkQET3MNr_JTDLprSytLRQFqeItZDKZbspMss0fZT6LX9Ysu4h4CuF93peQB6HXQNZABD2b7TSb4QwYW_N1y-EJWoGgpGJAfzxFK0JqVjWEtyfoRYwPhEAjOniOTgAaJkq4Qr83k3VWqwnvgr93PtqI_Yh3KlnjUsS_bNpio8K0VDGpe4O3eVYO23nOzg9mtLpwesE_bcgRf7i--f4RDzYaFQ0-xxvvUrB9Tta7_WyJK8BfP19g5QZ8h6dl3m29XpLBMffRJPyYlUs2qX3jJXo2qimaV8fzFH27urzbXFe3Xz7dbC5uK01JB1UNgjHTN8QIxbty6YZGC62EMnVTdxz0yIhmDe8HPvCWGUOGkYpmBN310BJ6it4fdssXPGYTk5xt1GaalDM-R8mB0Fp0tIBv_wMffA6uvE3WwAkjINoCkQOkg48xmFHugp1VWCQQubcmD9ZksSa5LNZK5c1xN_f75G_hqKkA746AisXVGJTTNv4zzBgtzv8AM3iiKQ</recordid><startdate>200107</startdate><enddate>200107</enddate><creator>BROWN, Arthur E</creator><creator>DOLAN, Matthew J</creator><creator>MALONE, John D</creator><creator>GARNER, Robin</creator><creator>BIRX, Deborah L</creator><creator>MICHAEL, Nelson L</creator><creator>ZHOU, Susan</creator><creator>PERFETTO, Stephen P</creator><creator>HAWKES, Clifton</creator><creator>ROBB, Merlin</creator><creator>LANE, James</creator><creator>MAYERS, Douglas</creator><creator>MCNEIL, John G</creator><general>Association of Military Surgeons</general><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88F</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M1Q</scope><scope>M2M</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>200107</creationdate><title>Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation</title><author>BROWN, Arthur E ; DOLAN, Matthew J ; MALONE, John D ; GARNER, Robin ; BIRX, Deborah L ; MICHAEL, Nelson L ; ZHOU, Susan ; PERFETTO, Stephen P ; HAWKES, Clifton ; ROBB, Merlin ; LANE, James ; MAYERS, Douglas ; MCNEIL, John G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3081-21966eb40e9a781968d4c9ca9ae242871cf60c647bd7d756ee0df394f1c8b1503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adult</topic><topic>AIDS</topic><topic>Biological and medical sciences</topic><topic>Chi-Square Distribution</topic><topic>Disease Progression</topic><topic>Female</topic><topic>HIV</topic><topic>HIV Infections - immunology</topic><topic>HIV-1</topic><topic>Human immunodeficiency virus</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immune system</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Lymphocyte Count</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical sciences</topic><topic>Outcome Assessment (Health Care)</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>RNA, Viral - blood</topic><topic>Statistics, Nonparametric</topic><topic>Survival Analysis</topic><topic>T-Lymphocyte Subsets</topic><topic>Vaccines</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BROWN, Arthur E</creatorcontrib><creatorcontrib>DOLAN, Matthew J</creatorcontrib><creatorcontrib>MALONE, John D</creatorcontrib><creatorcontrib>GARNER, Robin</creatorcontrib><creatorcontrib>BIRX, Deborah L</creatorcontrib><creatorcontrib>MICHAEL, Nelson L</creatorcontrib><creatorcontrib>ZHOU, Susan</creatorcontrib><creatorcontrib>PERFETTO, Stephen P</creatorcontrib><creatorcontrib>HAWKES, Clifton</creatorcontrib><creatorcontrib>ROBB, Merlin</creatorcontrib><creatorcontrib>LANE, James</creatorcontrib><creatorcontrib>MAYERS, Douglas</creatorcontrib><creatorcontrib>MCNEIL, John G</creatorcontrib><creatorcontrib>RGP160 Phase IIA Vaccine Investigators</creatorcontrib><creatorcontrib>RGP160 Phase IIA Vaccine Investigators</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Military Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Military Database</collection><collection>Psychology Database</collection><collection>ProQuest Science Journals</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Military medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BROWN, Arthur E</au><au>DOLAN, Matthew J</au><au>MALONE, John D</au><au>GARNER, Robin</au><au>BIRX, Deborah L</au><au>MICHAEL, Nelson L</au><au>ZHOU, Susan</au><au>PERFETTO, Stephen P</au><au>HAWKES, Clifton</au><au>ROBB, Merlin</au><au>LANE, James</au><au>MAYERS, Douglas</au><au>MCNEIL, John G</au><aucorp>RGP160 Phase IIA Vaccine Investigators</aucorp><aucorp>RGP160 Phase IIA Vaccine Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation</atitle><jtitle>Military medicine</jtitle><addtitle>Mil Med</addtitle><date>2001-07</date><risdate>2001</risdate><volume>166</volume><issue>7</issue><spage>571</spage><epage>576</epage><pages>571-576</pages><issn>0026-4075</issn><eissn>1930-613X</eissn><coden>MMEDA9</coden><abstract>Systems for the staging of individuals with human immunodeficiency virus type 1 (HIV-1) infection were developed 15 years ago. Subsequently, assays for quantitating HIV-1 RNA and immunophenotyping of lymphocyte subsets have been developed and validated. The utility of these assays for improved staging in early disease was evaluated in 256 HIV-infected adults (52% minority) with CD4 counts > or = 400 cells/microL followed in U.S. military medical centers before the highly active anti-retroviral therapy era. HIV viral load (RNA) was quantitated; the frequencies of select CD4+ immunophenotypes were determined in 112 subjects. The results were analyzed in relation to three outcome measures: death, first acquired immunodeficiency syndrome-defining opportunistic infection, and CD4 count < or = 200 cells/microL. Serum RNA level and CD4 count were each found to be predictive of all three outcomes. In addition, increases in the T-cell subsets CD28-CD4+ and CD29+CD26-CD4+ were found to be independently predictive of more rapid progression. The classification of early-stage HIV patients is improved by the quantitation of both viral RNA and T-lymphocyte subsets.</abstract><cop>Bethesda, MD</cop><pub>Association of Military Surgeons</pub><pmid>11469026</pmid><doi>10.1093/milmed/166.7.571</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0026-4075 |
ispartof | Military medicine, 2001-07, Vol.166 (7), p.571-576 |
issn | 0026-4075 1930-613X |
language | eng |
recordid | cdi_proquest_miscellaneous_71032983 |
source | Oxford Journals Online |
subjects | Acquired immune deficiency syndrome Adult AIDS Biological and medical sciences Chi-Square Distribution Disease Progression Female HIV HIV Infections - immunology HIV-1 Human immunodeficiency virus Human viral diseases Humans Immune system Infections Infectious diseases Lymphocyte Count Lymphocytes Male Medical prognosis Medical sciences Outcome Assessment (Health Care) Prognosis Proportional Hazards Models RNA, Viral - blood Statistics, Nonparametric Survival Analysis T-Lymphocyte Subsets Vaccines Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids |
title | Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A46%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20prognosis%20of%20patients%20with%20early-stage%20human%20immunodeficiency%20virus%20(HIV)%20disease%20:%20Contribution%20of%20HIV-1%20RNA%20and%20T%20lymphocyte%20subset%20quantitation&rft.jtitle=Military%20medicine&rft.au=BROWN,%20Arthur%20E&rft.aucorp=RGP160%20Phase%20IIA%20Vaccine%20Investigators&rft.date=2001-07&rft.volume=166&rft.issue=7&rft.spage=571&rft.epage=576&rft.pages=571-576&rft.issn=0026-4075&rft.eissn=1930-613X&rft.coden=MMEDA9&rft_id=info:doi/10.1093/milmed/166.7.571&rft_dat=%3Cproquest_cross%3E71032983%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3081-21966eb40e9a781968d4c9ca9ae242871cf60c647bd7d756ee0df394f1c8b1503%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217060195&rft_id=info:pmid/11469026&rfr_iscdi=true |